Lactate Dehydrogenase Test Market Research Report-Forecast till 2027

Lactate dehydrogenase test market information: by type (LD1, LD2, LD3, LD4, LD5) by indications (cerebrovascular diseases, liver diseases, blood disorders, others) by equipment (instruments, consumables, others) end users - Forecast till 2027

ID: MRFR/LS/2597-HCR | February 2021 | Region: Global | 90 Pages         

Lactate Dehydrogenase Test Market Speak to Analyst Request a Free Sample

Lactate Dehydrogenase Test Market Scenario:


Lactate dehydrogenase (LDH) is an enzyme occurring in most body tissues such as the liver, heart, pancreas, kidneys, muscles, blood cells etc. that is required for converting sugar into energy. The values of LDH are directly proportional to the disease condition of the body and during diseases the values of LDH increases denoting variety of conditions such as stroke, liver diseases, muscle dystrophy, fatigue etc.

The market for lactate dehydrogenase test is rising due to increasing occurrence of diseases such as cerebrovascular diseases, liver diseases, blood disorders, muscle dystrophy etc. Further fatigue testing due to increase in sports is also an important driver for the lactate dehydrogenase test market.

Considering all these factors the lactate dehydrogenase test market is expected to reach $ 6.4 billion by the end of 2023, this market is projected to growing at a CAGR of ~ 8.8 % during 2017-2023.

Study objectives:



  • To provide a detailed analysis of the market structure along with estimated future growth forecast for the next six years about various segments and sub-segments of the global lactate dehydrogenase test market

  • To provide insights about factors affecting the market growth

  • To analyze the global lactate dehydrogenase test market based on various factors - Price Analysis, Supply Chain Analysis, Porters Five Force analysis etc.

  • To provide past and estimated future revenue of the market’s segments and sub-segments with respect to four main geographies and their countries - the Americas, Europe, Asia Pacific along with Middle East & Africa

  • To provide country level analysis of the market with respect to the current market size and future growth prospects

  • To provide country level analysis of the market which includes segmentation by type, indications, equipment, and end users.

  • To provide overview of key players and their strategic profiling in the market, comprehensively analyzing their core competencies, and drawing a competitive landscape of the market

  • To track and analyze developments which are competitive in nature such as joint ventures, strategic alliances, mergers and acquisitions, new product developments along with research and developments that are currently taking place in the global lactate dehydrogenase test markets


Research Methodology

Sources: Mayo Clinic, MRFR Analysis


 Key players of Global Lactate dehydrogenase test Market:


Key players profiled in the report are LifeSpan BioSciences, Aviva Systems Biology, Accurex Biomedical Pvt. Ltd., Thermo Fisher Scientific, Bioo Scientific Corporation, Quest Diagnostics, Abcam plc., Randox Laboratories Ltd., Sigma-Aldrich Co. LLC., Merck KGaA and others.


Segments:


The global lactate dehydrogenase test market is segmented on the basis of type, indications, equipment, and end users. Based on type, the market has been segmented as lactate dehydrogenase 1 (LD1), lactate dehydrogenase 2 (LD2), lactate dehydrogenase 3 (LD3), lactate dehydrogenase 4 (LD4), and lactate dehydrogenase 5 (LD5). Based on the indications, the market has been segmented as cerebrovascular diseases, liver diseases, blood disorders, muscle dystrophy and fatigue, necrosis, infections, substance abuse, and others. Based on the equipment, the market has been segmented as instruments (spectroscope, centrifuge, others), consumables and others. Based on the end users, the market has been segmented as hospitals and clinics, diagnostic laboratories, academic and research and others.


Market Synopsis of Global Lactate Dehydrogenase Test Market:

Figure 1         Global Lactate dehydrogenase test Market, by Indications, 2016 (% Market Share)


 


 


Regional analysis


US accounts for the maximum market share due to favorable reimbursement scenario and greater expenditure on healthcare. The faster market uptake of new technology in the US is also an important driver of the market for global lactate dehydrogenase test. Europe is the second largest market due to large disposable income and rising awareness. Asia Pacific region is expected to have the most potential and it is estimated to be led by China and India. The Middle East & Africa market is led by the gulf nations particularly Saudi Arabia and UAE. The poor regions of Africa are expected to be a laggard due to poor economic and political conditions and poor healthcare penetration. The report for Global Lactate dehydrogenase test Market by Market Research Future comprises of extensive primary research along with the detailed analysis of qualitative as well as quantitative aspects by various industry experts, key opinion leaders to gain a deeper insight of the market and industry performance. The report gives a clear picture of the current market scenario which includes past and estimated future market size with respect to value and volume, technological advancement, macro economical and governing factors in the market. The report provides detail information about and strategies used by top key players in the industry. The report also gives a broad study of the different market segments and regions.
Intended Audience



  • Global Lactate dehydrogenase test, manufacturers & suppliers

  • Research and development (R&D) companies

  • Market research and consulting service providers

  • Academic institutes and universities



Report Scope:
Report Attribute/Metric Details
  Market Size   2023: $ 6.4 Billion
  CAGR   2017-2023:~ 8.8%
  Base Year   2019
  Forecast Period   2027
  Historical Data   2018
  Forecast Units   Value (USD Billion)
  Report Coverage   Revenue Forecast, Competitive Landscape, Growth Factors, and Trends
  Segments Covered   Type, Indications, Equipment and End Users
  Geographies Covered   North America, Europe, Asia-Pacific, and Rest of the World (RoW)
  Key Vendors   LifeSpan BioSciences, Aviva Systems Biology, Accurex Biomedical Pvt. Ltd., Thermo Fisher Scientific, Bioo Scientific Corporation, Quest Diagnostics, Abcam plc., Randox Laboratories Ltd., Sigma-Aldrich Co. LLC., Merck KGaA
  Key Market Opportunities   Favorable reimbursement scenario and greater expenditure on healthcare In US Market
  Key Market Drivers

  • Increasing occurrence of diseases such as cerebrovascular diseases, liver diseases, blood disorders, muscle dystrophy etc
  • Fatigue testing due to increase in sports


  • Speak to Analyst Ask for Customization

    Frequently Asked Questions (FAQ) :

    Lactate dehydrogenase test market size can touch 6.4 billion by 2023.

    Lactate dehydrogenase test market is set to accumulate revenues at 8.8% CAGR from 2017 to 2023.

    Rising incidence of cardiovascular diseases is the major growth driver of the global lactate dehydrogenase test market.

    The U.S. can drive global demand owing to the uptick witnessed in adoption of latest diagnostic tests and favorable reimbursement policies.

    Abcam plc., Aviva Systems Biology, Thermo Fisher Scientific, LifeSpan BioSciences, Accurex Biomedical Pvt. Ltd., Merck KGaA, Quest Diagnostics, Bioo Scientific Corporation, Sigma-Aldrich Co. LLC., and Randox Laboratories Ltd. are major players of the global lactate dehydrogenase test market.